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Abstract
Background: Mapping from non-performance-based measures onto generic performance-based measures provides an appropriate
solution to derive utilities to be used in economic evaluations.
Objectives: This study aimed to create a model through which EQ-5D utilities for cataracts can be obtained from scores on the
disease-specific Catquest measure.
Patients and Methods: One hundred ninety-nine observations from 103 patients who self-administered the EQ-5D, the Catquest
and questions on demographic and clinical characteristics were included in the analysis. Data was divided into estimation and
validation datasets. To predict EQ-5D utilities, multiple regression analysis, using the Ordinary Least Square (OLS) and the censored
least absolute deviation (CLAD), was performed. Catquest scores, age, gender, and performing surgery were included as explanatory
variables. An estimation dataset was used to derive the coefficients, and these coefficients were then validated using a validation
dataset. Based on the explanatory power, the consistency, the simplicity, the mean absolute error (MAE) and the correlations between
observed and fitted utilities, the most appropriate model was selected.
Results: The mean EQ-5D and Catquest scores of the total sample were 0.631 and 15.8, respectively. Age and surgery showed no
significant effect for either method. Removing age and surgery, model II was built and given an R2 of 0.697, an MAE of 0.1176 for the
OLS and an R2 of 0.614, and an MAE of 0.1153 for the CLAD method. In the validation stage, the CLAD revealed better prediction ability,
with an MAE of 0.198 versus an MAE of 0.209 for the OLS. ICC and Bland-Altman analysis put the CLAD as a preferred method with
the following equation: Utilities (EQ-5D) = 0.988 - 0.0281× Catquest (PD) + 0.102× gender (male = 1).
Conclusions: Based on these results, a mapping function was obtained which appears to be valuable in predicting EQ-5D utilities
from Catquest scores. This function gives an appropriate solution to estimate utilities when primary EQ-5D data is not available.
Although the model represents good consistency and predictive ability, further examination of obtained function is required with
large samples.
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1. Background
The existence of market failure in health care has
meant that economic evaluation has become inevitable.
Cost-utility analysis, using quality-adjusted life-years
(QALYs) as a single measure of outcomes, is one of the
most common forms of economic evaluation (1). QALYs
integrate both quantitative and qualitative aspects of life
in a single measure of health outcomes. In this context,
the quality of life is measured in terms of health-related
quality of life (HRQL) according to a preference-based
utility scale anchored at 0 (death) and 1 (full health),
although a negative value (states worse than death) is
possible. QALYs are calculated by incorporating these
values to length of time in each health state (2). There are
several generic, preference-based, quality of life measures,
and these generic instruments are featured in eliciting a
population’s preferences regarding the different health
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states. The EQ-5D (EuroQol 5D index) is one of the most
frequently-used, generic, preference-based measures, so
that population tariffs for this measure have been elicited
in a number of countries (3). Despite the significant
benefits of generic instruments in providing a unique
solution for the comparison of health outcomes across
interventions, these instruments, in comparison with
disease-specific instruments, suffer from a responsiveness
to small changes (4, 5). Therefore, when the interest is
in clinically important differences, because of the high
sensitivity, disease-specific instruments are preferred
(4). On the other hand, eliciting a population’s pref-
erences for each economic evaluation may require the
allocation of a lot of resources, and there also may be
previous studies or data collections that only included
disease-specific measures and not a generic measure (5,
6). Because disease-specific instruments cannot be used
to calculate QALYs, one way to deal with this limitation is
to map disease-specific scored measures to indexed values
obtained through the preference-based instruments.
Addressing these issues, mapping would provide us with
the estimation of QALYs where the preference-based
instruments were not included.
Cataracts are the leading cause of blindness through-
out the world (7). They are also the most common cause
of eye operations. The number of cataract operations that
will be performed throughout the world is projected to be
32 million by 2020 (8). For diseases like cataracts that are
chronic with long morbidity and a documented impact on
HRQL (9, 10), integrating HRQL data in the evaluation of
treatment is essential. HRQL can be measured based on
health utilities (HU) for use in economic evaluations to in-
form healthcare decision-making. The Catquest is a widely
used, disease-specific instrument that contains questions
useful for evaluating health-related quality of life pertain-
ing to cataract surgery. In addition, it is not a preference-
based measure (11).
2. Objectives
This study aimed to create a model to allow EQ-5D utili-
ties for cataracts to be obtained from scores on the disease-
specific Catquest measure.
3. Patients and Methods
3.1. Design and Recruitment
This is a longitudinal study with two points of mea-
surement that was approved by the ethics committee
of Kerman University of Medical Sciences in July 2013
(with code number “134.29”). The study was conducted in
Kashani hospital, a large, tertiary referral, government and
educational hospital with 15 departments and 1000 beds.
The hospital is affiliated with Shahrekord University of
Medical Sciences in Iran. Initially, 106 patients who were
scheduled for cataract surgery agreed to participate in the
study. The sample size was estimated using the rule of
thumb proposed by Green (12) for determining the mini-
mum sample size for regression analysis. Accordingly, the
size should be greater than 104 + K, where K represents
the number of independent variables. Patients were in-
cluded if they met the inclusion criteria as having con-
firmed cataract disease by an ophthalmologist, and if they
had given written informed consent. All participants were
reassured about confidentiality, and that participating in
the study did not influence the treatment they received
in any way. Three out of 106 patients did not consent to
participate and were excluded from the study. The 103 pa-
tients that met the inclusion criteria were consecutively re-
cruited between July 2013 and January 2014. Patients were
asked to self-administer the questionnaire package at two
points in time. The package included the EQ-5D, Catquest,
and questions on demographic characteristics. The first
administration was done while they were in the hospital,
and before they entered the hospital operating room. At
the end of the first administration, patients were informed
about the second administration, which would occur after
six months, and that the same questionnaire package with
a postage-paid return envelope enclosed would be sent to
their addresses. Keeping in mind the time it would take
the post to reach them, we had telephone contact with
patients to make sure that the packages were delivered.
Ninety-six out of 103 first-administered patients responded
at second administration; that is, we had a total of 199 ob-
servations.
3.2. Disease-Specific Instrument
The Catquest is a disease-specific questionnaire that
has been developed to assess visual disability through pa-
tients’ self-reported visual function. It consists of ques-
tions encompassing four dimensions of daily life: fre-
quency of doing activities (six questions), perceived dis-
ability (seven questions), cataract symptoms (two ques-
tions), and satisfaction with vision (two questions). For
perceived disability and cataract symptoms, there are four
response options as follows: 1 = no difficulty; 2 = some dif-
ficulty; 3 = much difficulty; 4 = extreme difficulty. Within
this range, higher scores correspond to worse visual dis-
ability. Response options in the area of satisfaction vary
from 1 (very satisfied) to 4 (very dissatisfied), with interme-
diate options for 2 and 3 corresponding to rather satisfied
and rather dissatisfied, respectively. The four response op-
tions for the frequency of doing activities are as follows: 1 =
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does the activity frequently; 2 = does the activity more fre-
quently; 3 = does the activity rarely; 4 = does not perform
the activity (11, 13, 14). The Catquest has demonstrated good
reliability and validity in cataract surgery (15). Based on the
previous studies, perceived disability domain is one of the
most important areas, and the correlation of this area with
utility is well documented (9). Therefore, the score sum of
the perceived disability (PD) domain was used for the main
analysis. By summing each score for each question, the to-
tal score sum for this domain is obtained. Thus, this score
is ranked between 7 (indicating the best score) and 28 (in-
dicating the worst score) (9).
3.3. Utilities
Utility values for this study were derived using the
EQ-5D instrument. The EQ-5D (3, 5) is a generic, stan-
dard, preference-based instrument that is used to indi-
rectly drive utility values. It consists of five dimensions
(mobility, self-care, usual activities, pain/discomfort, and
anxiety/depression), each of which has three response lev-
els (no problems, some problems, and extreme problems).
It gives a total of 243 health states. These health states
are assigned scores, using a tariff based on the time trade-
off method from a sample of 3,395 respondents from the
UK general population. Scoring ranges from -0.59 to 1.00,
with 0 indicating dead, 1 representing a state of full health,
and negative scores representing health states that are per-
ceived to be worse than death. The reliability and validity
of the EQ-5D have been well documented in different set-
tings (3, 16-18). Because there was no Iranian population
tariff for the EQ-5D when the study was conducted, the U.K.
scoring algorithm was used to drive utilities.
3.4. Analysis
In order to estimate EQ-5D index scores from Catquest
scores, multiple regression analysis was performed. The
utility index obtained from the EQ-5D was taken as the de-
pendent variable, and the summary score of perceived dis-
ability domain of the Catquest as the independent vari-
able, controlled for surgery, gender and age. Surgery and
gender were included as dummy variables and defined
with 0 (female) and 1 (male) for gender, and for surgery
by 0 (before) and 1 (after). Other studies have revealed
that there is a ceiling effect in EQ-5D index scores (19-21);
therefore, ordinary least squares (OLS) produce inaccurate
estimates. The Tobit and the censored Least absolute de-
viation (CLAD) methods are appropriate for right censor-
ing data (19, 20, 22). However, because the Tobit model is
performed under the assumptions of normality and ho-
moscedasticity, where these assumptions are violated, this
model also produces biased estimates (22). In contrast, be-
cause the CLAD method does not require normality and ho-
moscedasticity assumptions, it produces consistent esti-
mates (23). The CLAD is a reasonable alternative, even in the
presence of heteroscedasticity, non-normality, and censor-
ing. As is common with other studies (24) and for the pur-
pose of comparison, we used two OLS and CLAD methods
to estimate a mapping algorithm. We examined the good-
ness of fit by adjusted R2 and mean absolute error (MAE).
The total dataset was divided into two datasets, estima-
tion (60 percent) and validation (40 percent). The estima-
tion dataset was used to derive regression coefficients, and
the validation dataset was used to validate derived map-
ping functions of both the OLS and CLAD methods. The
performance of the models in the validation stage was as-
sessed in terms of mean absolute deviation between ob-
served and fitted utilities, correlation between predicted
and observed values and Bland-Altman analysis. All statis-
tical analyses were performed using STATA 12.0 and MedCal
13.0.6 software.
4. Results
4.1. Descriptive Summary
One hundred ninety-nine observations of the patients
with cataracts who self-administered the questionnaires
were included in the analysis. Of these, 119 (60 percent)
of the observations were in the estimation dataset, and 80
(40 percent) were in the validation dataset. Table 1 provides
the demographic and clinical characteristics of the total
sample. The mean age at the time of the operation was
59.2, most of the patients were females (56 percent), and
52 percent of the patients were in pre-operative and 48 per-
cent in post-operative states. Table 2 shows the mean EQ-
5D and Catquest (PD) scores in the pre-operative patients,
post-operative patients and in the total samples. The mean
index scores of the EQ-5D were 0.608, 0.778 and 0.631 in the
pre-operative patients, post-operative patients and in the
total sample, respectively. The mean Catquest (PD) scores
for the aforementioned samples were 21.8, 8.6 and 15.8, re-
spectively.
4.2. Regression Analysis
Table 3 presents the mapping models that were built,
using two OLS and CLAD methods, based on the estimation
dataset. Model I, using the OLS method (indicated on the
left side of Table 3), included the Catquest (PD), age, gen-
der and surgery as explanatory variables. These variables
explained about 0.693 (adjusted R2) of the variations and
gave an MAE of 0.1186. Age and surgery showed no statis-
tically significant effects. In addition, the coefficient for
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Table 1. Demographic and Clinical Characteristics of Patients Having Cataractsa
Characteristics Values
Mean age at operation in years 59.2 (5.5)
Female 112 (56)
Male 87 (44)
Pre-operative 103 (52)
Post-operative 96 (48)
aData are presented as No. (%), except for age, which is represented by mean
(SD).
age showed no expected sign that did not make sense. Re-
moving age and surgery from the regression equation, we
constructed model II, which adjusted R2 (0.697), and MAE
(0.1176) were consequently both improved. These two mod-
els (I, II) (Table 3, right-hand side) were then applied for
the CLAD method and given an R2 of 0.596, and an MAE of
0.1184 for model I; and an R2 of 0.614, and MAE of 0.1153 for
model II.
4.3. External Validation
Based on the explanatory power, consistency of the es-
timated coefficients, simplicity and mean absolute error
criteria, model II, for both the OLS and CLAD methods, was
adapted to be validated externally. Table 4 describes the
performance of the models in terms of the mean fitted EQ-
5D, the difference of the observed and fitted mean, and con-
fidence intervals for the fitted EQ-5D. The mean observed
EQ-5D for the validation dataset was 0.671. The fitted means
of the OLS and CLAD methods were 0.683 and 0.656, respec-
tively. As is obvious in terms of mean differences, the CLAD
method overestimated the mean EQ-5D, with 0.012 differ-
ences, and the OLS method underestimated the mean util-
ity value, with 0.015 differences. The differences for both
methods were below the minimal important differences
(MID) (0.074) for the EQ-5D (25).
The ICCs for fitted and observed utilities using the OLS
and CLAD methods were 0.498 and 0.506, respectively. Fig-
ure 1 and 2 show the Bland-Altman plot of the differences
between the observed and predicted utilities versus the
mean observed and fitted utilities for the OLS and CLAD
methods in the validation dataset, respectively. In general,
two plots showed reasonable agreement, and revealed that
a substantial proportion of the observations fell within the
area of zero ± 1.96 × (standard deviation) of the differ-
ences. In both methods, the differences between observed
and predicted values exceeded the MID.
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Figure 1. Bland-Altman Plots of Agreement Between Fitted and Observed Utilities
Using the OLS Method from Model II in the Validation Dataset
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Figure 2. Bland-Altman Plots of Agreement Between Fitted and Observed Utilities
Using the CLAD Method from Model II in the Validation Dataset
5. Discussion
The EQ-5D, as a generic measure, is frequently used
to derive utilities. On the other hand, the Catquest, as a
disease-specific measure, is used to assess the visual dis-
ability of patients with cataracts. Taking the benefits and
limitations of two generic and disease-specific measures
into account, mapping provides a useful way to derive utili-
ties for different health states. Several studies, using differ-
ent measures, have attempted to develop mapping equa-
tions in different areas of disease (24). In the present study,
the EQ-5D utilities regressed on Catquest scores, control-
ling for age, gender and surgery (Model I). In both the OLS
and CLAD methods, age and surgery gave no statistically
significant coefficients. This is most likely because of the
high correlation (> 0.80) between these variables, with
Catquest scores as another independent variable. Further-
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Table 2. Distribution of EQ-5D and Catquest (PD) Scores in Pre- and Post-operative Patientsa
OLS CLAD
Model I Model II Model I Model II
Catquest (PD) -0.0233 (0.0038) a -0.0278 (0.001) a -0.0246 (0.004) a -0.0281 (0.0021) a
Age 0.0001 (0.0826) - -0.0007 (0.0825) -
Gender 0.142 (0.0304) a 0.139 (0.0299)a 0.093 (0.0309) a 0.102 (0.025) a
Surgery 0.0840 (0.0639) - 0.0674 (0.0918) -
R2 0.693 b 0.697 b 0.596 c 0.614 c
MAE d 0.1186 0.1176 0.1184 0.1153
Constant 0.871 (0.188) 0.980 (0.034) a 0.982 (0.185) 0.988 (0.031) a
aData are presented as mean (SD).
Table 3. Regression of the EQ-5D Utility Index Upon Catquest (PD) by the Ordinary Least Square (OLS) and Censored Least Absolute Deviation (CLAD) Methods
OLS CLAD
Model I Model II Model I Model II
Catquest (PD) -0.0233 (0.0038) a -0.0278 (0.001) a -0.0246 (0.004) a -0.0281 (0.0021) a
Age 0.0001 (0.0826) - -0.0007 (0.0825) -
Gender 0.142 (0.0304) a 0.139 (0.0299)a 0.093 (0.0309) a 0.102 (0.025) a
Surgery 0.0840 (0.0639) - 0.0674 (0.0918) -
R2 0.693 b 0.697 b 0.596 c 0.614 c
MAE d 0.1186 0.1176 0.1184 0.1153
Constant 0.871 (0.188) 0.980 (0.034) a 0.982 (0.185) 0.988 (0.031) a
aSignificant (P < 0.05).
bAdjusted R
cPseudo R
dMean absolute error.
Table 4. Performance of Model II Using a Validation Dataset for two OLS and CLAD Methods
Mean Fitted EQ-5D Difference of Means (Observed-Fitted) Confidence Interval of Fitted EQ-5D MAE a
CLAD b 0.683 -0.012 (0.640 - 0.725) 0.198
OLS c 0.656 0.015 (0.608 - 0.707) 0.209
aMean absolute error.
bCensored least absolute deviation.
cOrdinary least square.
more, other studies obtained similar results for age (9).
Dropping two non-significant variables, we built model II.
The explanatory power, in terms of R2 and MAE, improved
either for the OLS and CLAD methods. The coefficient of
the Catquest was significant and consistent for both meth-
ods. Even though the amount of the coefficient was small,
considering the fact that the Catquest measures just that
aspect of quality of life that pertains to visual function,
and the EQ-5D measures aspects other than visual function,
this seems to be reasonable. This is consistent with results
that were obtained by other authors (9). In terms of ex-
planatory power, two methods showed somewhat similar
results. Even though R2 for the OLS was higher than that
for the CLAD, the MAE was also higher. Because the CLAD
offers pseudo R2, directly comparing this with adjusted R2
obtained from the OLS method is not methodologically
without limitations (26, 27). In comparison with results ob-
tained by others (9), these amounts appeared to be reason-
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able for both methods.
To give further assurance in determining the most ap-
propriate method, we used a separate dataset for valida-
tion of both methods. The CLAD revealed lower values
for the MAE and the difference between the mean of ob-
served and fitted utilities. In addition, the ICC between ob-
served and fitted utilities presented better agreement for
the CLAD method than the OLS. Furthermore, the Bland-
Altman plots showed similar patterns for two methods.
Both methods underestimated the utilities for higher val-
ues, and overestimated at lower values. Similar patterns
have been seen in the published mapping studies (28).
While most of the observations were within the area of
1.96 SD, the limits for the CLAD method were narrower (CI;
0.640 - 0.725) than those for the OLS (CI; 0.608 - 0.707).
Based on the baseline regression analysis and the vali-
dation dataset, this study suggests the CLAD method as be-
ing the preferred method, and the following equation as
a mapping function to derive utilities from Catquest (PD)
scores:
Utilities (EQ− 5D) = 0.988− 0.0281× Catquest (PD)
+ 0.102× gender (male
= 1)
(1)
Some other studies have suggested the CLAD as be-
ing the preferred choice in mapping literature (19). This
study provides an easy way for clinicians and other re-
searchers to derive utilities from a disease-specific mea-
sure when primary EQ-5D data is not available in patients
with cataracts. In addition, this study investigates the per-
formance of two different methods and chooses the most
appropriate method. Despite these advantages, there are
two limitations of this study. First, the sample size used in
the present study was small. Second, participants were not
assigned randomly, although they were recruited consecu-
tively and controlled for some variables. The results of this
study should be used cautiously, particularly when other
directly-obtained, social preference-based values are avail-
able.
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